Future therapies for cystic fibrosis

Future therapies for cystic fibrosis

The cystic fibrosis landscape has changed dramatically over the last few decades, with improvements in patient quality of life, prognosis and predicted survival. In part, this is related to the availability of novel CFTR modulator drugs, although prior advances in symptom-directed therapies and diag...

Full description

Bibliographic Details
Main Authors:	Lucy Allen, Lorna Allen, Siobhan B. Carr, Gwyneth Davies, Damian Downey, Marie Egan, Julian T. Forton, Robert Gray, Charles Haworth, Alexander Horsley, Alan R. Smyth, Kevin W. Southern, Jane C. Davies
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-02-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-023-36244-2

Similar Items

Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)
by: Aditi Sinha, et al.
Published: (2021-09-01)

Book review: Hodson and Geddes’ Cystic Fibrosis
by: Alex Horsley
Published: (2016-03-01)

Why Do We Screen Newborn Infants for Cystic Fibrosis?
by: Jürg Barben, et al.
Published: (2020-07-01)

Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis
by: Rachael E. Armstrong, et al.
Published: (2020-05-01)

Gene therapy for the treatment of cystic fibrosis
by: Burney TJ, et al.
Published: (2012-05-01)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
by: Caitlyn Harvey, et al.
Published: (2022-03-01)

Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
by: Karen Keown, et al.
Published: (2020-11-01)

Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis
by: Francis J. Gilchrist, et al.

International Approaches to Management of CFTR-Related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis
by: Jane Chudleigh, et al.
Published: (2022-01-01)

A grumbling concern: A survey of gastrointestinal symptoms in cystic fibrosis in the modulator era [version 2; peer review: 1 approved, 4 approved with reservations]
by: Vinishaa Premakumar, et al.
Published: (2024-02-01)

A grumbling concern: an international survey of gastrointestinal symptoms in cystic fibrosis in the modulator era [version 1; peer review: 1 approved, 3 approved with reservations]
by: Vinuja Premakumar, et al.
Published: (2023-04-01)

Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine
by: Afsoon Sepahzad, et al.
Published: (2021-04-01)

Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis.
by: Hyde, S, et al.
Published: (2000)

Exploring the mechanisms of macrolides in cystic fibrosis.
by: Equi, A, et al.
Published: (2006)

Bacterial Culture Underestimates Lung Pathogen Detection and Infection Status in Cystic Fibrosis
by: Helen Gavillet, et al.
Published: (2022-10-01)

Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?
by: Alex eHorsley, et al.
Published: (2011-12-01)

“Reactance inversion” at low frequencies in a child undergoing treatment of a cystic fibrosis exacerbation
by: Julian Lewis Allen, et al.
Published: (2019-12-01)

Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus
by: Zara I Kirkwood, et al.
Published: (2018-01-01)

Stakeholder Views of the Proposed Introduction of Next Generation Sequencing into the Cystic Fibrosis Screening Protocol in England
by: Pru Holder, et al.
Published: (2024-02-01)

Psychological Impact on Parents of an Inconclusive Diagnosis Following Newborn Bloodspot Screening for Cystic Fibrosis: A Qualitative Study
by: Faye Johnson, et al.
Published: (2019-06-01)

Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome
by: Ryan Marsh, et al.
Published: (2023-10-01)

Clinical improvement in cystic fibrosis following anti-tumourous chemotherapy.
by: Eisen, S, et al.
Published: (2004)

Using social media to improve communication with people with cystic fibrosis
by: Christina Dale, et al.
Published: (2016-03-01)

Nebuliser hygiene in cystic fibrosis: evidence-based recommendations
by: Jane Bell, et al.
Published: (2020-06-01)

Non-antimicrobial airway management of non-cystic fibrosis bronchiectasis
by: Ashley M. Egan, et al.
Published: (2018-01-01)

Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His
by: Michal Shteinberg, et al.
Published: (2017-03-01)

Lung clearance index in adults with non-cystic fibrosis bronchiectasis.
by: Gonem, S, et al.
Published: (2014)

Lung clearance index in adults with non-cystic fibrosis bronchiectasis
by: Gonem, S, et al.
Published: (2014)

Cystic fibrosis
by: Radlović Nedeljko
Published: (2012-01-01)

Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
by: Davies, L, et al.
Published: (2014)

Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis
by: Lucy Perrem, et al.
Published: (2020-09-01)

Curvilinearity provides additional information to lung clearance index only in a minority of children with early cystic fibrosis lung disease
by: Samantha Irving, et al.
Published: (2022-04-01)

Physical activity for cystic fibrosis: perceptions of people with cystic fibrosis, parents and healthcare professionals
by: Sarah Denford, et al.
Published: (2020-09-01)

The cost-effectiveness of palivizumab in infants with cystic fibrosis in the Canadian setting: A decision analysis model
by: Ashleigh A. McGirr, et al.
Published: (2017-03-01)

Going the Extra Mile: Why Clinical Research in Cystic Fibrosis Must Include Children
by: Rebecca Dobra, et al.
Published: (2022-07-01)

Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
by: Giuseppe Fabio Parisi, et al.
Published: (2022-05-01)

Lung function imaging methods in Cystic Fibrosis pulmonary disease
by: Magdalena Kołodziej, et al.
Published: (2017-05-01)

Sustained Glycemic Control With Ivacaftor in Cystic Fibrosis–Related Diabetes
by: Francis Christian MD, et al.
Published: (2019-04-01)

A poly-functional gene delivery system for cystic fibrosis
by: Montier, T, et al.
Published: (2017)

Lung function and microbiota diversity in cystic fibrosis
by: Leah Cuthbertson, et al.
Published: (2020-04-01)